Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.
Since Nov 18, 2025
Transactions
14
Purchases
5
Sales
9
Purchase value
$573.29K
Sale value
$9.90M
Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.
Brian G. LloydCHIEF LEGAL OFFICER, SECRETARY
4Rule 10b5-1 plan disclosed
Filed Nov 17, 2026Period of report Nov 16, 20260001671772-26-000008
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 16, 2026
Common Stock, No Par ValueF1F2
16,722
$86.325
$1.44M
60,132
Direct
Filing footnotes · 6
F1The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2026.
F2The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.88 to $86.90, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3Become exercisable in equal annual installments of 25% commencing on 02/26/2021.
F4Become exercisable in equal annual installments of 25% commencing on 03/19/2022.
F5Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.
F6Become exercisable in equal annual installments of 25% commencing on 02/28/2024.
Filed Aug 25, 2026Period of report Aug 24, 20260001926221-26-000008
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleAug 24, 2026
Common Stock, No Par ValueF1
7,500
$90.448
$678.36K
18,051
Direct
Filing footnotes · 3
F1The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.43 to $90.53, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2Becomes exercisable in equal annual installments of 25% commencing 08/19/2022.
F3Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.
Filed May 11, 2026Period of report May 7, 20260001786127-26-000002
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 7, 2026
Common Stock, No Par ValueF1
5,000
$62.607
$313.04K
7,809
Direct
Filing footnotes · 1
F1The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.395 to $62.815, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Filed Jan 8, 2026Period of report Jan 6, 20260001926221-26-000002
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 6, 2026
Common Stock, No Par ValueF1
5,000
$90.00
$450.00K
28,369
Direct
Filing footnotes · 4
F1The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2024.
F2Becomes exercisable in equal annual installments of 20% commencing 04/25/2020.
F3Becomes exercisable in equal annual installments of 25% commencing 08/19/2022.
F4Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.
Filed Nov 26, 2025Period of report Nov 25, 20250000901534-25-000011
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 25, 2025
Common Stock, No Par ValueF3
10,000
$88.0377
$880.38K
1,019,955
Direct
Filing footnotes · 6
F1Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse.
F2The 401(k) number represents plan holdings as of 10/31/2025.
F3The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.00 to $88.175, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.
F5Becomes exercisable in equal annual installments of 25% commencing 3/19/2022.
F6Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.
Filed Nov 24, 2025Period of report Nov 21, 20250000901534-25-000009
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 21, 2025
Common Stock, No Par ValueF3
25,000
$87.31
$2.18M
1,029,955
Direct
Filing footnotes · 6
F1Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse.
F2The 401(k) number represents plan holdings as of 10/31/2025.
F3The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.0000 to $87.6708, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.
F5Becomes exercisable in equal annual installments of 25% commencing 3/19/2022.
F6Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.
Filed Nov 21, 2025Period of report Nov 20, 20250000901534-25-000007
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 20, 2025
Common Stock, No Par ValueF3
20,000
$85.1325
$1.70M
1,054,955
Direct
Filing footnotes · 6
F1Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse.
F2The 401(k) number represents plan holdings as of 10/31/2025.
F3The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.01 to $86.3499, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.
F5Becomes exercisable in equal annual installments of 25% commencing 3/19/2022.
F6Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.
Filed Nov 20, 2025Period of report Nov 18, 20250000901534-25-000005
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 18, 2025
Common Stock, No Par ValueF3
5,000
$84.826
$424.13K
1,074,955
Direct
Filing footnotes · 6
F1Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse.
F2The 401(k) number represents plan holdings as of 10/31/2025.
F3The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.03 to $86.44, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.
F5Becomes exercisable in equal annual installments of 25% commencing 3/19/2022.
F6Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.
P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.